MDSpire - Summary
Clinical Guidelines

Your Biological Age? It's in the Blood

Multi-marker model may refine risk prediction and preventive testing

  • April 1, 2026

  • 2 min

Share

The European MARK-AGE study reveals that a panel of 10 blood-based biomarkers can more accurately estimate biological age than chronological age, potentially aiding disease risk prediction. Analyzing over 3,300 individuals aged 35 to 74, researchers developed algorithms based on sex-specific biomarkers, demonstrating that a multi-marker approach better reflects systemic aging. Key findings indicate that biological age disparities provide crucial insights, as certain biomarkers, such as HDL cholesterol and vitamin D, correlate with a younger biological profile. This innovative approach opens avenues for personalized preventative care in aging-related conditions.

Original Source(s)

Your Biological Age? It's in the Blood

  • April 1, 2026

Related Content

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

PFAS Exposure Linked to Faster Epigenetic Aging 

Epigenetic clock analysis ties PFNA exposure to faster biological aging, particularly in men aged 50–64 

  • April 1, 2026

  • 2 min
Prednisolone Linked to Metabolic Benefits

A randomized crossover trial found slower bone turnover and no safety differences compared with standard hydrocortisone regimens